clinical trial · NCT02042300
XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice
Seung-Jung Park·—·completed·n = 4,000
Percutaneous Transluminal Coronary AngioplastyCoronary Artery DiseaseXIENCE Xpedition/Alpine/Sierra
brief summary
The purpose of this study is to evaluate effectiveness and safety of XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice
started
May 1, 2014
primary completion
Jul 1, 2020
completion
Aug 30, 2024
last updated
Dec 29, 2025
official title
Evaluation of Effectiveness and Safety of XIENCE Xpedition/Alpine/Sierra in Routine Clinical Practice; A MULTICENTER, PROSPECTIVE OBSERVATIONAL STUDY
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol